Aerie Pharmaceuticals
AERI
$15.25
Share price
0.00%
Change (1 day)
83.73%
Change (1 year)
Categories
Market capitalization of Aerie Pharmaceuticals (AERI)
Market cap: $0.75 Billion
As of April 2024 Aerie Pharmaceuticals has a market cap of $0.75 Billion. This makes Aerie Pharmaceuticals the world's 5489th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Aerie Pharmaceuticals from 2013 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.75 B | 0% |
| 2023 | $0.75 B | 0% |
| 2022 | $0.75 B | 121.6% |
| 2021 | $0.34 B | -46.24% |
| 2020 | $0.63 B | -43.67% |
| 2019 | $1.12 B | -31.6% |
| 2018 | $1.64 B | -25.14% |
| 2017 | $2.19 B | 73.57% |
| 2016 | $1.26 B | 96.12% |
| 2015 | $0.64 B | -8.11% |
| 2014 | $0.70 B | 67.64% |
| 2013 | $0.41 B |
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Merck MRK | $329.29 B | 43,595.22% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | $0.38 B | -49.36% | 🇺🇸 USA |
 Insmed INSM | $3.72 B | 394.58% | 🇺🇸 USA |